Pasithea Therapeutics (KTTA) Intangibles (2022 - 2026)

Pasithea Therapeutics has reported Intangibles for 5 years, with the latest figure at $3.6 million in Q1 2026.

• Quarterly Intangibles fell 57.73% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 57.73% YoY) and the FY2025 annual result came in at $8.6 million, up 17.24% from the prior year.
• Intangibles declined to $3.6 million in Q1 2026 per KTTA's latest filing, from $8.6 million in the prior quarter.
• Over five years, Intangibles peaked at $8.6 million in Q4 2022 and troughed at $12502.0 in Q3 2022.
• A 5-year average of $7.4 million and a median of $8.4 million in 2023 frame the typical range for Intangibles.
• The sharpest annual moves came in 2023 and 2026: Intangibles jumped 64680.48% in 2023, then plunged 57.73% in 2026.
• Over 5 years, Intangibles stood at $8.6 million in 2022, then changed by 0.0% to $8.6 million in 2023, then dropped by 14.7% to $7.3 million in 2024, then grew by 17.24% to $8.6 million in 2025, then slumped by 57.73% to $3.6 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $3.6 million, $8.6 million, and $8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.